[Experimental and clinical observations on the action of a new anti-angina drug: 3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine lactate or FPDFPA].
D001713:Biphenyl Compounds; D002317:Cardiovascular Agents; D003327:Coronary Disease; D006801:Humans; D007773:Lactates; D019344:Lactic Acid; D011299:Prenylamine; D011437:Propylamines
D001713:Biphenyl Compounds; D002317:Cardiovascular Agents; D007773:Lactates; D019344:Lactic Acid; D011299:Prenylamine; D011437:Propylamines; C010574:biphenyl
CORONARY DISEASE; SEGONTIN